Sectors & IndustriesHealthcare
Best Healthcare Stocks to Buy Now (2026)
Top healthcare stocks in 2026 ranked by overall Due Diligence Score. See the best healthcare stocks to buy now, according to analyst forecasts for the healthcare sector.

Sector: Healthcare

Overview Zen Rating Price Value Growth Financials

Momentum Sentiment Forecast Dividends Due Diligence

Ticker	Company	Market Cap	ROE	ROA	ROCE	ROIC	D/E	Current Ratio	Gross Margin	Profit Margin	Operating Margin
IMTX	IMMATICS NV	$1.37B	-47.10%	-39.10%	-44.13%	-108.70%	0.19	8.78	100.00%	-574.90%	-577.38%
IKT	INHIBIKASE THERAPEUTICS INC	$261.42M	-41.30%	-39.00%	-30.40%	-108.00%	0.03	30.14	N/A	N/A	N/A
LNSR	LENSAR INC	$74.93M	-183.20%	42.30%	60.70%	114.00%	3.86	2.38	45.70%	50.90%	50.94%
ABEO	ABEONA THERAPEUTICS INC	$359.64M	41.40%	29.50%	41.69%	57.30%	0.37	5.89	70.90%	454.90%	480.13%
RNAC	CARTESIAN THERAPEUTICS INC	$303.80M	N/A	-45.90%	-59.08%	-107.40%	-2.95	7.65	100.00%	-8,698.70%	-9,068.56%
STXS	STEREOTAXIS INC	$184.72M	-258.10%	-47.60%	-70.07%	-207.70%	2.40	1.56	53.90%	-73.60%	-69.50%
SRRK	SCHOLAR ROCK HOLDING CORP	$6.63B	-163.50%	-96.70%	-84.39%	-216.20%	0.94	8.64	N/A	N/A	N/A
TNXP	TONIX PHARMACEUTICALS HOLDING CORP	$202.61M	-67.70%	-60.50%	-64.57%	-349.20%	0.14	6.99	58.60%	-839.50%	-839.52%
SLDB	SOLID BIOSCIENCES INC	$1.09B	-74.50%	-62.00%	-48.85%	-120.70%	0.13	13.10	N/A	N/A	N/A
STOK	STOKE THERAPEUTICS INC	$2.02B	-48.80%	-42.30%	-46.04%	-74.00%	0.12	8.99	100.00%	-529.20%	-577.65%
CRVS	CORVUS PHARMACEUTICALS INC	$1.28B	-38.90%	-35.70%	-18.32%	-44.40%	0.05	19.81	N/A	N/A	N/A
SPRY	ARS PHARMACEUTICALS INC	$827.20M	-153.60%	-60.80%	-81.11%	-52.70%	3.69	4.94	74.10%	-200.00%	-194.99%
NKTX	NKARTA INC	$236.10M	-30.90%	-24.20%	-28.24%	-23.70%	0.30	12.96	N/A	N/A	N/A
ZNTL	ZENTALIS PHARMACEUTICALS INC	$336.00M	-53.60%	-40.70%	-56.73%	-46.50%	0.39	6.19	N/A	N/A	N/A
RARE	ULTRAGENYX PHARMACEUTICAL INC	$3.32B	N/A	-45.70%	-62.33%	-38.20%	-6.28	2.02	83.50%	-90.90%	-90.37%
SPRB	SPRUCE BIOSCIENCES INC	$142.71M	-155.40%	-101.70%	-82.16%	1,096.50%	0.62	4.67	N/A	N/A	N/A
GANX	GAIN THERAPEUTICS INC	$77.20M	-201.40%	-136.20%	-136.66%	1,668.10%	0.34	4.69	N/A	N/A	N/A
ARVN	ARVINAS INC	$545.20M	-44.40%	-28.40%	-41.57%	-41.20%	0.67	5.44	100.00%	-247.50%	-247.20%
CMND	CLEARMIND MEDICINE INC	$2.38M	-143.80%	-88.50%	-68.36%	694.30%	0.26	4.79	N/A	N/A	N/A
ZLAB	ZAI LAB LTD	$2.14B	-24.30%	-15.50%	-24.75%	-138.50%	0.66	2.40	57.90%	-39.30%	-38.37%
UPB	UPSTREAM BIO INC	$402.71M	-43.80%	-42.30%	-51.50%	-55.90%	0.05	23.14	100.00%	-4,719.00%	-4,718.96%
CLDX	CELLDEX THERAPEUTICS INC	$2.98B	-50.70%	-46.60%	-61.69%	-55.90%	0.12	8.92	100.00%	-32,753.60%	-32,753.58%
RXRX	RECURSION PHARMACEUTICALS INC	$2.10B	-54.30%	-40.60%	-46.65%	-311.60%	0.31	5.47	7.20%	-842.90%	-849.83%
AKTX	AKARI THERAPEUTICS PLC	$0.00	-123.30%	-63.00%	-141.42%	225.20%	1.36	0.27	N/A	N/A	N/A
CRBP	CORBUS PHARMACEUTICALS HOLDINGS INC	$166.75M	-70.90%	-61.80%	-66.90%	-88.60%	0.14	7.92	N/A	N/A	N/A
IRON	DISC MEDICINE INC	$2.94B	-36.90%	-33.90%	-33.06%	-39.40%	0.09	24.00	N/A	N/A	N/A
TLSA	TIZIANA LIFE SCIENCES LTD	$140.99M	-924.30%	-161.80%	-6,444.41%	1,249.60%	220.06	0.76	N/A	N/A	N/A
LITS	LITE STRATEGY INC	$33.21M	-90.80%	-89.30%	-107.01%	-108.90%	0.02	11.53	N/A	N/A	N/A
SCYX	SCYNEXIS INC	$46.97M	-57.20%	-39.50%	-39.72%	-70.10%	0.88	3.94	100.00%	-120.50%	-120.51%
STEX	STREAMEX CORP	$113.66M	-719.70%	-337.20%	-290.97%	1,449.50%	0.09	13.90	N/A	N/A	N/A
ORGO	ORGANOGENESIS HOLDINGS INC	$319.11M	-7.20%	-3.60%	0.67%	0.80%	0.57	3.53	72.90%	-3.60%	0.58%
MGX	METAGENOMI THERAPEUTICS INC	$47.06M	-51.20%	-36.60%	-49.32%	-40.60%	0.43	6.43	100.00%	-384.60%	-385.27%
MDAI	SPECTRAL AI INC	$59.51M	N/A	-78.80%	362.42%	423.10%	-3.01	0.75	46.00%	-82.00%	-75.74%
AVIR	ATEA PHARMACEUTICALS INC	$389.73M	-57.00%	-51.50%	-75.24%	-81.10%	0.14	7.89	N/A	N/A	N/A
ZBIO	ZENAS BIOPHARMA INC	$1.67B	-167.70%	-97.40%	-59.88%	-161.80%	1.23	11.94	N/A	N/A	N/A
IMVT	IMMUNOVANT INC	$7.92B	-68.20%	-62.20%	-59.28%	4,013.20%	0.12	9.09	N/A	N/A	N/A
CAPR	CAPRICOR THERAPEUTICS INC	$1.30B	-59.30%	-48.60%	-38.12%	-105.00%	0.17	8.42	N/A	N/A	N/A
HUMA	HUMACYTE INC	$171.18M	-2,781.60%	-85.40%	-92.26%	-80.30%	8.51	3.93	-475.00%	-4,840.80%	-4,318.95%
OCS	OCULIS HOLDING AG	$856.18M	-56.80%	-45.60%	-47.03%	-99.90%	0.24	5.18	100.00%	-7,889.60%	-7,850.54%
DYN	DYNE THERAPEUTICS INC	$3.78B	-58.30%	-46.80%	-42.90%	-114.60%	0.25	19.92	N/A	N/A	N/A
PRCT	PROCEPT BIOROBOTICS CORP	$1.21B	-27.70%	-20.30%	-26.18%	-45.70%	0.40	6.73	64.00%	-31.80%	-34.43%
BHVN	BIOHAVEN LTD	$2.42B	-866.50%	-138.00%	-156.05%	-152.70%	2.60	7.41	N/A	N/A	N/A
ZURA	ZURA BIO LTD	$509.19M	-76.80%	-65.90%	-34.39%	568.20%	0.05	19.33	N/A	N/A	N/A
ANRO	ALTO NEUROSCIENCE INC	$920.16M	-47.20%	-38.80%	-27.32%	-305.80%	0.14	20.52	N/A	N/A	N/A
RNXT	RENOVORX INC	$42.75M	-138.60%	-104.60%	-101.87%	2,924.70%	0.24	7.15	78.70%	-824.00%	-823.98%
VRDN	VIRIDIAN THERAPEUTICS INC	$1.96B	-60.70%	-50.60%	-47.85%	-65.40%	0.24	15.15	100.00%	-508.50%	-497.44%
VNDA	VANDA PHARMACEUTICALS INC	$374.64M	-61.40%	-44.60%	-50.25%	-65.50%	0.54	2.16	94.20%	-110.00%	-68.74%
ARCT	ARCTURUS THERAPEUTICS HOLDINGS INC	$208.91M	-36.60%	-28.40%	-37.28%	-272.80%	0.28	6.31	100.00%	-143.80%	-143.80%
RKTO	ROCKET ONE INC	$17.39M	-165.20%	-143.60%	-280.82%	-3,991.50%	0.34	3.39	N/A	N/A	N/A
PRQR	PROQR THERAPEUTICS NV	$185.26M	-86.20%	-38.40%	-68.68%	-3,620.80%	1.63	2.48	100.00%	-333.50%	-322.16%
XENE	XENON PHARMACEUTICALS INC	$5.85B	-49.20%	-46.40%	-28.59%	-70.10%	0.04	27.79	N/A	N/A	N/A
PMN	PROMIS NEUROSCIENCES INC	$122.95M	-238.00%	-151.00%	-66.81%	761.30%	0.11	9.92	N/A	N/A	N/A
SABS	SAB BIOTHERAPEUTICS INC	$299.74M	-0.30%	-0.30%	-0.07%	-0.10%	0.09	11.45	N/A	N/A	N/A
RGNX	REGENXBIO INC	$766.68M	-232.50%	-61.00%	-90.43%	-42.20%	15.22	2.62	68.20%	-330.20%	-278.82%
BCYC	BICYCLE THERAPEUTICS PLC	$303.68M	-35.70%	-29.50%	-36.03%	-465.30%	0.18	12.66	100.00%	-345.00%	-342.41%
CNTX	CONTEXT THERAPEUTICS INC	$58.62M	-60.00%	-54.80%	-76.88%	1,376.90%	0.13	8.96	N/A	N/A	N/A
AUTL	AUTOLUS THERAPEUTICS PLC	$433.83M	-128.60%	-46.30%	-54.09%	-32.90%	3.84	5.80	-11.20%	-312.00%	-270.67%
RXST	RXSIGHT INC	$231.82M	-17.00%	-15.10%	-16.83%	-17.40%	0.14	10.20	77.00%	-36.60%	-36.53%
IRD	OPUS GENETICS INC	$331.28M	N/A	-223.00%	-185.80%	1,046.20%	-1.92	7.13	100.00%	-892.40%	-890.71%
KROS	KEROS THERAPEUTICS INC	$218.30M	-17.00%	-15.80%	-30.16%	-214.50%	0.09	22.62	100.00%	-256.60%	-272.15%
SENS	SENSEONICS HOLDINGS INC	$235.35M	-130.00%	-67.20%	-107.76%	-71.70%	2.00	3.51	52.10%	-214.20%	-202.58%
CRNX	CRINETICS PHARMACEUTICALS INC	$4.43B	-44.00%	-39.60%	-37.30%	-43.80%	0.09	18.60	92.90%	-2,747.20%	-2,746.18%
MIST	MILESTONE PHARMACEUTICALS INC	$164.34M	-339.40%	-61.80%	-35.49%	-52.90%	4.37	9.18	99.20%	-3,832.00%	-3,437.50%
TCRX	TSCAN THERAPEUTICS INC	$68.62M	-91.90%	-50.10%	-66.76%	-76.90%	1.08	6.65	100.00%	-1,360.60%	-1,330.19%
SDGR	SCHRODINGER INC	$1.27B	-30.80%	-15.30%	-21.99%	-26.40%	1.02	2.74	55.30%	-40.60%	-40.08%
OSTX	OS THERAPIES INC	$71.71M	N/A	-422.40%	364.62%	417.70%	-1.58	0.05	N/A	N/A	N/A
ONCY	ONCOLYTICS BIOTECH INC	$105.03M	N/A	-322.30%	-1,208.00%	1,534.50%	-2.59	1.38	N/A	N/A	N/A
ORIC	ORIC PHARMACEUTICALS INC	$1.13B	-35.30%	-33.30%	-32.27%	-41.00%	0.05	16.33	N/A	N/A	N/A
PRME	PRIME MEDICINE INC	$720.66M	-188.80%	-61.00%	-76.76%	-60.10%	2.84	3.80	100.00%	-4,917.60%	-4,917.55%
FEED	ENVUE MEDICAL INC	$3.15M	-101.10%	-80.30%	-75.13%	1,046.50%	0.25	0.90	-12.40%	-1,720.50%	-1,136.91%
OLMA	OLEMA PHARMACEUTICALS INC	$1.12B	-45.90%	-41.20%	-38.30%	-51.00%	0.10	10.88	N/A	N/A	N/A
TRAW	TRAWS PHARMA INC	$11.77M	-859.20%	-126.00%	291.96%	220.20%	-2.54	0.43	100.00%	-539.70%	-539.70%
TECX	TECTONIC THERAPEUTIC INC	$664.57M	-32.30%	-30.90%	-35.19%	8,093.00%	0.07	18.51	N/A	N/A	N/A
FBRX	FORTE BIOSCIENCES INC	$417.97M	-106.20%	-85.50%	-170.84%	641.40%	0.60	2.75	N/A	N/A	N/A
FTH	FAETH THERAPEUTICS INC	$32.86M	N/A	-256.50%	-96.47%	-879.10%	-0.10	14.39	N/A	N/A	N/A
GPCR	STRUCTURE THERAPEUTICS INC	$3.89B	-15.10%	-14.40%	-11.70%	-21.30%	0.04	26.16	N/A	N/A	N/A
IVVD	INVIVYD INC	$245.70M	-53.50%	-41.60%	-36.94%	-396.90%	0.19	6.47	92.90%	-138.90%	-138.90%
PCVX	VAXCYTE INC	$8.22B	-32.50%	-29.50%	-30.47%	-33.20%	0.12	7.49	N/A	N/A	N/A
ELDN	ELEDON PHARMACEUTICALS INC	$306.44M	-150.30%	-53.90%	-59.65%	-64.20%	1.03	8.44	N/A	N/A	N/A
PROK	PROKIDNEY CORP	$601.10M	N/A	-21.40%	-27.15%	-33.50%	-0.03	9.06	100.00%	-8,131.50%	-8,149.27%
ATOS	ATOSSA THERAPEUTICS INC	$19.63M	-84.90%	-72.40%	-123.47%	2,579.00%	0.25	4.92	N/A	N/A	N/A
NRIX	NURIX THERAPEUTICS INC	$2.49B	-64.20%	-48.40%	-54.15%	-64.00%	0.32	6.01	100.00%	-411.40%	-410.31%
ELTX	ELICIO THERAPEUTICS INC	$62.89M	-2,748.20%	-151.10%	-251.11%	-271.50%	-16.79	2.24	N/A	N/A	N/A
CING	CINGULATE INC	$70.36M	-365.20%	-158.50%	-139.27%	-960.40%	0.64	2.55	N/A	N/A	N/A
KRRO	KORRO BIO INC	$202.78M	-117.90%	-71.00%	-66.79%	-73.30%	0.54	8.13	100.00%	-2,954.10%	-2,935.09%
BBOT	BRIDGEBIO ONCOLOGY THERAPEUTICS INC	$673.70M	-61.50%	-41.00%	-41.16%	-122.10%	0.12	6.16	N/A	N/A	N/A
XNCR	XENCOR INC	$1.10B	-28.80%	-20.50%	-21.41%	-15.70%	0.43	6.57	100.00%	-177.10%	-145.89%
MSLE	SATELLOS BIOSCIENCE INC	$172.27M	N/A	N/A	N/A	N/A	0.07	16.48	N/A	N/A	N/A
EPRX	EUPRAXIA PHARMACEUTICALS INC	$402.99M	-53.50%	-51.20%	-32.22%	-215.30%	0.07	19.30	N/A	N/A	N/A
AKAN	AKANDA CORP	$9.51M	N/A	-647.10%	1,222,546.98%	-642.50%	-1.52	0.58	-60.50%	-17,690.20%	-18,048.64%
LENZ	LENZ THERAPEUTICS INC	$175.58M	-46.80%	-43.30%	-43.97%	-52.80%	0.11	10.40	92.90%	-519.30%	-516.91%
AARD	AARDVARK THERAPEUTICS INC	$130.68M	-61.70%	-56.30%	-80.32%	-99.60%	0.13	8.06	N/A	N/A	N/A
CRVO	CERVOMED INC	$33.05M	-136.10%	-112.60%	-282.94%	-221.00%	0.42	3.36	100.00%	-1,437.80%	-1,437.83%
EYPT	EYEPOINT INC	$1.21B	-110.50%	-90.20%	-108.21%	-131.50%	0.25	6.66	76.50%	-3,566.60%	-3,563.19%
TYRA	TYRA BIOSCIENCES INC	$1.84B	-42.70%	-39.80%	-33.38%	-55.30%	0.06	20.49	N/A	N/A	N/A
ACB	AURORA CANNABIS INC	$159.75M	-30.80%	-22.10%	-30.04%	-32.20%	0.17	5.94	42.60%	-51.30%	-50.05%
VERA	VERA THERAPEUTICS INC	$2.88B	-74.90%	-60.20%	-62.68%	-71.90%	0.24	13.64	N/A	N/A	N/A
HELP	CYBIN INC	$304.11M	-74.30%	-63.40%	-63.85%	-487.90%	0.08	9.52	N/A	N/A	N/A
CRDF	CARDIFF ONCOLOGY INC	$88.88M	-95.50%	-71.50%	-128.96%	-123.40%	0.42	3.27	100.00%	-8,530.90%	-8,526.10%
PSTV	PLUS THERAPEUTICS INC	$27.88M	-198.50%	-73.10%	-100.86%	1,062.90%	0.67	2.27	100.00%	-230.20%	-232.81%

Healthcare Industries

Industry	Stocks	1d %	1w %	1m %	1y %	P/E ratio	P/B Ratio	ROE	ROA	ROCE	Upside/Downside	Consensus
Biotechnology	607	-0.35%	+1.25%	+17.06%	+23.30%	18.36x	5.58x	-117.23%	-12.44%	-9.70%	+53.25%	Strong Buy
Diagnostics & Research	52	-0.02%	+3.31%	+13.74%	+24.32%	12.22x	3.90x	-7.05%	+5.99%	+11.73%	+5.79%	Strong Buy
Drug Manufacturers - General	20	-1.78%	-1.15%	+6.00%	+41.69%	41.49x	7.69x	+34.41%	+12.47%	+22.05%	+5.17%	Buy
Drug Manufacturers - Specialty & Generic	76	-0.55%	+0.67%	+5.56%	-33.67%	-5.96x	1.59x	+7.48%	+4.58%	+50.37%	+33.52%	Strong Buy
Healthcare Plans	10	-1.69%	+1.38%	+4.28%	+24.98%	29.47x	2.54x	+8.80%	+2.75%	+6.81%	-4.37%	Buy
Health Information Services	53	+0.95%	+5.82%	+18.00%	-47.94%	13.03x	3.44x	-8.71%	-0.43%	-0.74%	+17.15%	Buy
Medical Care Facilities	49	-0.40%	+5.21%	+14.56%	-22.16%	16.94x	5.47x	-49.37%	+6.58%	+14.89%	+11.00%	Buy
Medical Devices	135	+0.32%	+2.05%	+7.00%	-99.44%	20.88x	3.11x	+6.02%	+5.31%	+8.92%	+25.36%	Strong Buy
Medical Distribution	10	-0.08%	+4.19%	+6.35%	+10.62%	25.05x	156.87x	-97.12%	+3.72%	+24.95%	+17.15%	Buy
Medical Instruments & Supplies	54	+0.29%	+3.84%	+8.63%	-1.99%	45.23x	3.44x	+5.72%	+6.68%	+10.17%	+19.56%	Strong Buy

Healthcare Stocks FAQ

What are the best healthcare stocks to buy right now in Jul 2026?

According to Zen Ratings, our proprietary rating system that evaluates 115 factors proven to drive growth in stocks and assigns each stock in our system an overall letter grade as well as 7 individual Component Grades for Value, Growth, Momentum, Sentiment, Safety, Financials, and proprietary AI algorithms, the 3 best healthcare stocks to buy right now are:

1. Bioventus (NASDAQ:BVS)

Bioventus (NASDAQ:BVS) is the #1 top healthcare stock out of 1066 with a Zen Rating of A. Stocks with a rating of A have had an average return of +28.5% per year. Learn more.

The Component Grade breakdown for Bioventus (NASDAQ:BVS) is: Value: B, Growth: A, Momentum: B, Sentiment: A, Safety: B, Financials: B, and AI: C.

Bioventus (NASDAQ:BVS) has a Due Diligence Score of 44, which is 18 points higher than the healthcare sector average of 26. It passed 14 out of 33 due diligence checks and has strong fundamentals. Bioventus has seen its stock return 72.73% over the past year, overperforming other healthcare stocks by 168 percentage points.

Bioventus has an average 1 year price target of $15.00, an upside of 27.33% from Bioventus's current stock price of $11.78.

Bioventus stock has a consensus Strong Buy recommendation according to Wall Street analysts. Of the 3 analysts covering Bioventus, 33.33% have issued a Strong Buy rating, 66.67% have issued a Buy, 0% have issued a Hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.

2. Immucell (NASDAQ:ICCC)

Immucell (NASDAQ:ICCC) is the #2 top healthcare stock out of 1066 with a Zen Rating of A. Stocks with a rating of A have had an average return of +28.5% per year. Learn more.

The Component Grade breakdown for Immucell (NASDAQ:ICCC) is: Value: B, Growth: A, Momentum: B, Sentiment: C, Safety: C, Financials: B, and AI: B.

Immucell (NASDAQ:ICCC) has a Due Diligence Score of 19, which is -7 points lower than the healthcare sector average of 26. Although this number is below the industry average, our proven quant model rates ICCC as a "A".It passed 6 out of 33 due diligence checks and has weak fundamentals. Immucell has seen its stock return 53.94% over the past year, overperforming other healthcare stocks by 149 percentage points.

3. Electromed (NYSEMKT:ELMD)

Electromed (NYSEMKT:ELMD) is the #3 top healthcare stock out of 1066 with a Zen Rating of A. Stocks with a rating of A have had an average return of +28.5% per year. Learn more.

The Component Grade breakdown for Electromed (NYSEMKT:ELMD) is: Value: C, Growth: C, Momentum: B, Sentiment: A, Safety: B, Financials: A, and AI: C.

Electromed (NYSEMKT:ELMD) has a Due Diligence Score of 44, which is 18 points higher than the healthcare sector average of 26. It passed 15 out of 33 due diligence checks and has strong fundamentals. Electromed has seen its stock return 130.17% over the past year, overperforming other healthcare stocks by 225 percentage points.

Electromed has an average 1 year price target of $38.00, a downside of -17.94% from Electromed's current stock price of $46.31.

Electromed stock has a consensus Strong Buy recommendation according to Wall Street analysts. Of the 2 analysts covering Electromed, 100% have issued a Strong Buy rating, 0% have issued a Buy, 0% have issued a Hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.

What are the healthcare stocks with highest dividends?

Out of 74 healthcare stocks that have issued dividends in the past year, the 3 healthcare stocks with the highest dividend yields are:

1. Dominari Holdings (NASDAQ:DOMH)

Dominari Holdings (NASDAQ:DOMH) has an annual dividend yield of 33.28%, which is 31 percentage points higher than the healthcare sector average of 2.65%.

Dominari Holdings's dividend payout ratio of -19.1% indicates that its high dividend yield might not be sustainable for the long-term.

2. Siga Technologies (NASDAQ:SIGA)

Siga Technologies (NASDAQ:SIGA) has an annual dividend yield of 16%, which is 13 percentage points higher than the healthcare sector average of 2.65%.

Siga Technologies's dividend payout ratio of 206.9% indicates that its high dividend yield might not be sustainable for the long-term.

3. Embecta (NASDAQ:EMBC)

Embecta (NASDAQ:EMBC) has an annual dividend yield of 14.02%, which is 11 percentage points higher than the healthcare sector average of 2.65%.

Embecta's dividend payout ratio of 31.2% indicates that its high dividend yield is sustainable for the long-term.

Why are healthcare stocks down?

Healthcare stocks were down -0.32% in the last day, and up 2.16% over the last week. Adapthealth was the among the top losers in the healthcare sector, dropping -4.55% yesterday.

AdaptHealth shares are trading lower after Baird lowered its price target on the stock from $18 to $15.

What are the most undervalued healthcare stocks?

Based on the Valuation rating, one of the 7 components of a stocks overall Zen Ratings grade, which evaluates factors including estimated earnings yield, earnings before interest and taxes/enterprise value, cash flow yield, free cash flow to price, and price-to-earnings growth (PEG ratio), the 3 most undervalued healthcare stocks right now are:

1. Embecta (NASDAQ:EMBC)

Embecta (NASDAQ:EMBC) is the most undervalued healthcare stock based on its Valuation Rating of A. Valuation is one of 7 Component Grades used to calculate the overall Zen Rating.

Embecta has a valuation score of 43, which is 30 points higher than the healthcare sector average of 13. It passed 3 out of 7 valuation due diligence checks.

Embecta's stock has dropped -67.3% in the past year. It has overperformed other stocks in the healthcare sector by 27 percentage points.

2. Ironwood Pharmaceuticals (NASDAQ:IRWD)

Ironwood Pharmaceuticals (NASDAQ:IRWD) is the second most undervalued healthcare stock based on its Valuation Rating of A. Valuation is one of 7 Component Grades used to calculate the overall Zen Rating.

Ironwood Pharmaceuticals has a valuation score of 86, which is 73 points higher than the healthcare sector average of 13. It passed 6 out of 7 valuation due diligence checks.

Ironwood Pharmaceuticals's stock has gained 514.31% in the past year. It has overperformed other stocks in the healthcare sector by 609 percentage points.

3. Inmode (NASDAQ:INMD)

Inmode (NASDAQ:INMD) is the third most undervalued healthcare stock based on its Valuation Rating of A. Valuation is one of 7 Component Grades used to calculate the overall Zen Rating.

Inmode has a valuation score of 57, which is 44 points higher than the healthcare sector average of 13. It passed 4 out of 7 valuation due diligence checks.

Inmode's stock has dropped -3.31% in the past year. It has overperformed other stocks in the healthcare sector by 91 percentage points.

Are healthcare stocks a good buy now?

61.98% of healthcare stocks rated by analysts are a strong buy right now. On average, analysts expect healthcare stocks to rise by 27.99% over the next year.

5.22% of healthcare stocks have a Zen Rating of A (Strong Buy), 13.31% of healthcare stocks are rated B (Buy), 48.38% are rated C (Hold), 26% are rated D (Sell), and 7.09% are rated F (Strong Sell).

What is the average p/e ratio of the healthcare sector?

The average P/E ratio of the healthcare sector is 29.6x.

WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.

Sectors & IndustriesHealthcare
Best Healthcare Stocks to Buy Now (2026)
Top healthcare stocks in 2026 ranked by overall Due Diligence Score. See the best healthcare stocks to buy now, according to analyst forecasts for the healthcare sector.

Healthcare Industries

Healthcare Stocks FAQ

1. Bioventus (NASDAQ:BVS)

2. Immucell (NASDAQ:ICCC)

3. Electromed (NYSEMKT:ELMD)

1. Dominari Holdings (NASDAQ:DOMH)

2. Siga Technologies (NASDAQ:SIGA)

3. Embecta (NASDAQ:EMBC)

1. Embecta (NASDAQ:EMBC)

2. Ironwood Pharmaceuticals (NASDAQ:IRWD)

3. Inmode (NASDAQ:INMD)

Company

Stock Tools

Stock Ideas

Sectors & IndustriesHealthcareBest Healthcare Stocks to Buy Now (2026)Top healthcare stocks in 2026 ranked by overall Due Diligence Score. See the best healthcare stocks to buy now, according to analyst forecasts for the healthcare sector.

Healthcare Industries

Healthcare Stocks FAQ

1. Bioventus (NASDAQ:BVS)

2. Immucell (NASDAQ:ICCC)

3. Electromed (NYSEMKT:ELMD)

1. Dominari Holdings (NASDAQ:DOMH)

2. Siga Technologies (NASDAQ:SIGA)

3. Embecta (NASDAQ:EMBC)

1. Embecta (NASDAQ:EMBC)

2. Ironwood Pharmaceuticals (NASDAQ:IRWD)

3. Inmode (NASDAQ:INMD)

Company

Stock Tools

Stock Ideas

Sectors & IndustriesHealthcare
Best Healthcare Stocks to Buy Now (2026)
Top healthcare stocks in 2026 ranked by overall Due Diligence Score. See the best healthcare stocks to buy now, according to analyst forecasts for the healthcare sector.